Carbapenem-resistant pathogens cause infections associated with significant morbidity and mortality. This study evaluates the use of the loop-mediated isothermal amplification (LAMP) assay for rapid and cost-effective detection of bla NDM-1 and bla KPC genes among carbapenem-resistant Gram-negative bacteria in comparison with conventional PCR and existing phenotypic methods. A total of 60 carbapenem-resistant clinical isolates [Escherichia coli (15), Klebsiella pneumoniae (22), Acinetobacter baumannii (23)] were screened for the presence of carbapenemases (bla KPC and bla NDM-1 ) using phenotypic methods such as the modified Hodge test (MHT) and combined disc test (CDT) and molecular methods such as conventional PCR and LAMP assay. In all, 47/60 isolates (78.3 %) were MHT positive while 48 isolates were positive by CDT [46.6 % positive with EDTA, 30 % with 39 aminophenylboronic acid (APB) plus EDTA and 1.6 % with APB alone].
INTRODUCTION
The carbapenems are antimicrobials commonly used to treat infections caused by multidrug-resistant pathogens. Production of carbapenemases is the most common mechanism of resistance to this class of antibacterial agents in clinically important Gram-negative bacteria (GNB). Among the several carbapenemases, Klebsiella pneumoniae carbapenemase (KPC) enzymes, belonging to class A (serine carbapenemases) and inhibited by boronic acid, have rapidly become a global problem among the Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii (Robledo et al., 2011) . Some isolates expressing the KPC enzyme demonstrate low-level carbapenem resistance, but when combined with other cellular changes, such as porin loss, the MIC for the carbapenems increases. The gene encoding the KPC enzyme is usually flanked by transposon-related sequences and has been identified on conjugative plasmids; therefore, the potential for dissemination is significant (Woodford et al., 2004) .
Laboratory detection of the KPC resistance mechanism has been hampered by the heterogeneous expression of b-lactam resistance (Anderson et al., 2007) . Some bacterial clones encoding the bla KPC gene appear to be susceptible in vitro to carbapenems by reference Clinical and Laboratory Standards Institute (CLSI) agar dilution or broth microdilution methods as well as by automated identification systems, such as Vitek2 (Bio Merieux) (Anderson et al., 2007; Tenover et al., 2006) . New Delhi metallo-beta-lactamase (NDM-1), described in 2009 in K. pneumoniae, is a newer type of metallo-betalactamase (MBL) of the Ambler class B beta-lactamases that are inhibited by EDTA (Yong et al., 2009 ).
Since traditional or automated antimicrobial susceptibility systems show variable sensitivity in the detection of carbapenem resistance, it is recommended that subsequent phenotypic confirmatory tests are performed, such as the modified Hodge test (MHT) and the combined disc test (CDT) (Tenover et al., 2006) . However, these phenotypic assays have poor performance with turnaround times that are not clinically useful. Recently, molecular diagnostic techniques, such as real-time PCR, have been shown to be sensitive and accurate methods for identifying the presence of bla NDM-1 and bla KPC genes (Cole et al., 2009; Manchanda et al., 2011) .
The newly introduced loop-mediated isothermal amplification (LAMP) assay has emerged as a powerful gene amplification tool and is being used increasingly for the rapid identification of microbial infections (Liu et al., 2012; Notomi et al., 2000; Reddy et al., 2010) ; it appears to be a promising platform for the detection of bla NDM-1 and bla KPC.
Compared to PCR, LAMP has the advantages of reaction simplicity and detection sensitivity with a rapid turnaround time of 2-3 h. LAMP assay has great potential for identifying bla NDM-1 and bla KPC genes as a cost-effective and point-of-care tool.
In this study, we evaluated and compared a newly developed LAMP assay for the detection of bla NDM-1 and bla KPC genes with existing phenotypic methods and conventional PCR.
METHODS
A total of 60 carbapenem-resistant, clinically significant, nonduplicated Gram-negative isolates were included in this study (15 E. coli, 22 K. pneumoniae and 23 A. baumanii). Identification and antimicrobial susceptibility were carried out with the Vitek 2 system, using the ID GN and the N90 AST panels. Vitek 2 Advanced Expert System (AES) analysis findings of the enzyme profiles were recorded for comparison with confirmatory phenotypic and molecular assays.
Phenotypic tests (MHT and CDT) were performed with all 60 study isolates. MHT was carried out following CLSI guidelines (CLSI, 2012) . CDT (Yong et al., 2002) was performed using Mueller-Hinton agar (Merck) with 10 mg of meropenem (BD) disc and 10 ml (600 mg) of APB (Sigma) and 0.5 M EDTA (Himedia) per disc. An increase in the zone of inhibition of ¢4 mm with APB indicates the presence of KPC and ¢7 mm with EDTA indicates presence of an MBL.
Molecular detection of bla NDM-1 and bla KPC genes. DNA extraction was carried out according to the Centers for Disease Control and Prevention (CDC) protocol by the boiling method (from all 60 isolates and ATCC standard strains) (commercially procured from Sterisure).
K. pneumoniae ATCC strain BAA1705 (positive control for bla KPC ) and K. pneumoniae ATCC strain BAA 1706 (negative control for bla KPC and bla NDM genes) were used as per the CDC protocol (Lonsway et al., 2010) .
A clinical isolate of K. pneumoniae, harbouring the bla NDM-1 gene, identified by PCR and gene sequencing (Bioserve) was included as positive control for NDM-1, since a standard ATCC strain with bla NDM-1 was not available.
Design of the primers for detection of 16S rRNA, bla KPC and bla NDM-1 (Lonsway et al., 2010; Yong et al., 2009) . The primers used for each of the target genes, 16S rRNA, bla KPC and bla NDM-1 of GNB followed the protocol of Lonsway et al. (2010) . 16SrRNA primers were used as an internal control for bacterial DNA. The sequences of the primers are shown in Table 1 .
Conventional PCR assay. A 51 bp region of bla NDM 21 , 60 bp region of bla KPC and 158 bp region of 16S rRNA were amplified through conventional PCR assay using NDM-1, KPC, 16S rRNA specific primers (synthesized at Active Oligos).
The Quick-load Taq 2X PCR Master Mix (New England BioLabs) was used. Thermal cycling (Perkin Elmer) was carried out at 95 uC, 58 uC and 68 uC, for 30 s each. The final extension step was performed for 10 min at 68 uC using the thermal cycler. The PCR product containing amplicons was analysed in a 2 % agarose gel in 61 Tris acetate buffer at 90 V for 1 h and was visualized with ethidium bromide using a gel documentation system (Syngene).
LAMP assay. bla NDM-1 and bla KPC specific forward outer primer (F3), backward outer primer (B3), forward inner primer (FIP) and backward inner primer (BIP) were designed with the help of the Primer Explorer V4 software (http://primerexplorer.jp:81/lamp/). The two additional loop primers [forward loop primer (FLP) and backward loop primer (BLP)] were designed to accelerate the amplification reaction (Notomi et al., 2000) . All LAMP primers were synthesized commercially (Active Oligos).
PCR was performed with the F3 and B3 primers as forward and reverse primers to confirm their specificity. Detection of LAMP products was by: (1) visual fluorescence by adding 0.2 ml of 1/10000 DMSO SYBR1 Green I (Invitrogen) to 25 ml of LAMP product (Fig. 1) ; (2) 10 ml of the LAMP product was electrophoresed on 2 % agarose gel and documented using a gel documentation system (Syngene).
RESULTS
The 60 Gram-negative clinical isolates were mostly from critically ill patients admitted to intensive care units. Clinical samples included blood and aspirated body fluids or wound discharges.
Out of the 60 carbapenem-resistant GNB isolates, 47 (78.3 %) were MHT positive, indicating the presence of carbapenemases. MHT was positive in 11/15 (73.3 %) E. coli, 19/22 (86.3 %) K. pneumoniae and 17/23 (73.9 %) A. baumanii isolates (Table 2 ). In the CDT, 28 isolates showed an enhanced zone of inhibition with 0.5 M EDTA suggesting MBL production, while 19 isolates were positive with APB plus 0.5 M EDTA suggesting the presence of both KPC and MBL. Only one E. coli isolate was positive with APB suggesting KPC production alone. A comparison between the phenotypic and the genotypic detection of carbapenem resistance is shown in Table 2 .
The results of the PCR and LAMP assay for the target genes are shown in Table 3 . LAMP detected the resistance genes in four isolates that were missed by repeated conventional PCR; these were further confirmed by sequencing (Bioserve).
16S rRNA was detected in DNA extracts of all 60 isolates by PCR. The most frequent resistance gene was bla NDM-1 (47/ 60, 78.3 %), while the bla KPC gene was less frequent (20/60, 33.3 %). Of these, 19 bla KPC -positive isolates also had an associated bla NDM-1 gene, while it was a lone gene in one E. coli isolate. Neither gene could be detected in 12/60 (20 %) isolates. A comparison of the LAMP versus PCR results was statistically significant (P,0.05).
DISCUSSION
Carbapenemases, a group of clinically important blactamases that efficiently hydrolyse most b-lactams have emerged and spread globally. Timely detection, and confirmation of the presence of carbapenemases is important for surveillance, infection control and treatment purposes. Detection of carbapenem resistance using in vitro procedures with high performance parameters must be available at the point of care to be clinically useful.
Instrument-based automated antimicrobial susceptibility testing, such as Vitek 2, may not always distinguish between carbapenemase producing strains and those carrying other mechanisms of resistance [e.g. extendedspectrum beta-lactamases (ESBLs) and/or porin loss]. This was also possible in our study, as the Vitek 2 AES did not specify the enzyme profiles. They may also have lower MICs to carbapenem antimicrobials and therefore remain undetected. Hence, it is recommended that a phenotypic confirmatory test be performed for all clinically important carbapenemases (ECDC, 2011).
The MHT and the CDT are easy to implement and perform at the bench, but their performance parameters are poor, especially for the MHT. Hence interpretations should be made very cautiously (ECDC, 2011) . The presence of other resistance mechanisms, such as ESBLs and/or porin loss, may cause false detection (false-positive MHT) of a carbapenemase (Pasteran et al., 2010) . Likewise, NDM-1-producing isolates may cause false-negative results by the MHT (ECDC, 2011). The MHT is standardized for KPC detection among Enterobacteriacae and may produce variable results with MBLs especially among nonfermenters (CLSI, 2012) . In the present study, two isolates with presence of both or either of the bla NDM-1 and bla KPC genes gave negative results in the MHT. A positive MHT result in the absence of bla NDM-1 and bla KPC genes in one A. baumanii isolate can probably be explained by presence of other genes such as bla OXA .
To circumvent false-positive results the MHT was standardized with the addition of boronic acid (BA) and oxacillin (OXA), as inhibitors (Pasteran et al., 2010) . The use of these revised inhibitor-based methods (BA/OXA-MHT) results in significant reductions in false-positive results, in addition to distinguishing strains producing class A carbapenemases from strains producing other classes of carbapenemases, unlike the MHT (Pasteran et al., 2010) .
In the present study, the CDT was positive in all 48 (100 %) isolates possessing bla NDM-1 and bla KPC genes. In addition to the above limitations, both phenotypic assays are growth dependent and hence their turnaround time of 18-24 h is of limited clinical use.
Conventional and real-time PCR assays require sophisticated instrumentation and technical expertise. They are also time-consuming and expensive. The higher sensitivity and specificity of the LAMP assay, documented herein in comparison to PCR, is attributed to continuous amplification under isothermal conditions employing six specific primers recognizing eight distinct regions of the target. The higher sensitivity of the LAMP reaction can be confirmed by titration experiments. It only requires a simple water bath and hence is cost effective. In addition, the gene amplification can be visualized by the naked eye, either as turbidity in the form of a white precipitate or through a colour change employing a fluorescent intercalating dye (SYBER1 GREEN I) (Notomi et al., 2000) .
The reported prevalence of carbapenem resistance among E. coli, Klebseilla spp., Pseudomonas spp. and Acinetobacter spp. ranges from 2 % to 80 % in various parts of India (Wattal et al., 2010) ; these were shown to carry the bla NDM-1 gene (Deshpande et al., 2010; Kumarasamy et al., 2010; Walsh et al., 2011) . The present study also documents that bla NDM-1 is more common (47/60 isolates, 78.3 %) than bla KPC suggesting a high prevalence of bla NDM-1 from this geographical region. This gene was found in a similar proportion among all three Gram-negative species studied. MHT: sensitivity, 97.9 %; specificity 91.7 %; positive predictive value 97.9 %; negative predictive value 91.6 %. CDT: sensitivity, 100 %; specificity 100 %; positive predictive value 100 %; negative predictive value 100 %. LAMP assay for detection of bla NDM-1 and bla KPC genes
CONCLUSIONS
Our results suggest that the CDT should be preferred over the MHT for the detection of carbapenemases, especially MBLs. There are very few published data for KPC from India. To the best of our knowledge this is the first report on use of the LAMP assay for detection of the bla KPC gene and the second report for the combined detection of the bla NDM-1 and bla KPC genes from India.
The LAMP assay was found to be more sensitive than conventional PCR allowing detection of bla NDM-1 and bla KPC genes in four isolates that were not detected by PCR. Finally, with a turnaround time of only 2-3 h, the LAMP assay developed for the detection of these resistance genes can be considered as a point-of-care assay. 
